US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

114.70

+1.621.43%

Volume:49.41K

Turnover:5.68M

Market Cap:1.03B

PE:92.94

High:115.80

Open:115.15

Low:114.40

Close:113.08

52wk High:118.00

52wk Low:85.91

Shares:8.99M

Float Shares:8.99M

Volume Ratio:0.61

T/O Rate:0.55%

Dividend:2.17

Dividend Rate:1.89%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):147.72

Loading ...

Overview Company News Filings

Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths

NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novartis Says Remibrutinib Significantly Reduces Relapse Rates in Phase 3 Multiple Sclerosis Trials

MT Newswires Live

Eli Lilly (LLY) Eyes Merida Deal As Trial Data Strengthens Autoimmune Push

Simply Wall St.

New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":114.7,"timestamp":1788275437111,"preClose":113.08,"halted":0,"volume":49414,"delay":0,"changeRate":0.014326140785284795,"floatShares":8988138,"shares":8988138,"eps":1.234146,"marketStatus":"Trading","change":1.62,"latestTime":"09-01 11:10:46 EDT","open":115.15,"high":115.8,"low":114.4,"amount":5678596.10078,"amplitude":0.012381,"askPrice":114.74,"askSize":353,"bidPrice":114.69,"bidSize":55,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":113.08,"sharesOutstanding":11938138,"nav":113.68833,"aum":1038899632.53,"dividendRate":0.01892,"bidAskSpread":0.000372,"preHourTrading":{"tag":"盘前","latestPrice":114.73,"preClose":113.08,"latestTime":"09:29 EDT","volume":87,"amount":9948.38997,"timestamp":1788269399001,"change":1.65,"changeRate":0.014591,"amplitude":0.013265},"postHourTrading":{"tag":"盘后","latestPrice":113.08,"preClose":113.08,"latestTime":"19:30 EDT","volume":73,"amount":8292.6357,"timestamp":1788219002632,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.613728,"impliedVol":0.1763,"impliedVolPercentile":0.3492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":8988138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.613728,"shares":8988138,"dividePrice":2.1701,"high":115.8,"amplitude":0.012381,"preClose":113.08,"low":114.4,"week52Low":85.9086,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":114.7,"committee":-0.730392,"eps":1.234146,"divideRate":0.01892,"volume":49414,"delay":0,"ttmEps":1.234146,"open":115.15,"prevYearClose":103.17,"prevWeekClose":113.62,"prevMonthClose":113.08,"prevQuarterClose":109.35,"fiveDayClose":117.87,"twentyDayClose":108.15,"sixtyDayClose":105.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"},{"date":"2025-07-01","symbol":"PPH","amount":0.6069,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664527668","title":"Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664527668","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664527668?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:27","pubTimestamp":1788272820,"startTime":"0","endTime":"0","summary":"1427 GMT - Novartis's latest trial results for a multiple sclerosis drug suggest a multibillion-dollar sales opportunity is within the Swiss drugmaker's reach, analysts at J.P. Morgan say in a research note. The results for Novartis's Rhapsido reduce risk on a sales opportunity of at least $2 billion to $3 billion in relapsing multiple sclerosis alone, according to JPM. Given that consensus forecasts for 2030 sales from the drug currently stand at $3.4 billion, mainly from skin conditions, consensus estimates could see significant upgrades after the results, the analysts say. That said, detailed data are required to assess the drug's potential relative to Roche's fenebrutinib and so-called anti-CD20 therapies, a different class of medicines, they add. Novartis shares jump 6.3%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","PPH","BK4532","BK4578","LU0070302665.USD","IE0009355771.USD","LU0211331839.USD","IE00B2B36J28.USD","MEDX","LU0320765489.SGD","BK4588","IE00BJT1NW94.SGD","BK4007","IE00BJJMRZ35.SGD","NVS","IE0002141913.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852288","title":"Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852288","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664852288?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:17","pubTimestamp":1788272261,"startTime":"0","endTime":"0","summary":"Novartis ($NVS) stock rose about 6% at the time of writing on Tuesday, after the Swiss drugmaker reported positive results from two late-stage tria...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novartis-stock-nvs-pops-as-multiple-sclerosis-drug-shows-positive-results-in-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novartis-stock-nvs-pops-as-multiple-sclerosis-drug-shows-positive-results-in-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","LU0208291251.USD","BK4532","PPH","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4007","IE0002141913.USD","IE00B4R5TH58.HKD","BK4588","NVS","BK4585","BK4578","LU0320765489.SGD","LU0070302665.USD","IE00BJJMRZ35.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664785240","title":"Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664785240","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664785240?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:15","pubTimestamp":1788272126,"startTime":"0","endTime":"0","summary":"• Remibrutinib succeeded in Phase III multiple sclerosis trials, showing clinical superiority.\n• Novartis paused eight early-stage CAR-T trials following three patient deaths.\n• The company reports $56.33B annual revenue and $13.98B net profit.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262144163-market-movers-nvs-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BFTCPJ56.SGD","BK4578","LU0208291251.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","MEDX","LU0070302665.USD","BK4585","BK4532","IE0002141913.USD","PPH","NVS","IE00BJJMRZ35.SGD","LU0211331839.USD","IE00B2B36J28.USD","IE0009355771.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150852","title":"Novartis's Multiple Sclerosis Trial Results Match Best Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150852","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150852?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:14","pubTimestamp":1788272040,"startTime":"0","endTime":"0","summary":"1414 GMT - Novartis's trial results for a multiple sclerosis drug are in line with a blue-sky scenario, UBS analysts say in a research note. The Swiss drugmaker's results from two late-stage studies point to a greater reduction in annualized relapse rates with its Rhapsido compared to Sanofi's Aubagio, with no liver safety issues, the analysts say. These results suggest Novartis's drug might be at least a best-in-class oral medicine for the disease, according to UBS. UBS estimates that there's a 50% probability the drug's sales for relapsing multiple sclerosis reach $4.5 billion. Novartis shares jump 6.2%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1863844749.USD","IE0009355771.USD","LU0208291251.USD","LU3187612489.SGD","PPH","BK4118","SOCL","IE00BJT1NW94.SGD","BK4578","BK4077","IE00B4R5TH58.HKD","LU0240878834.USD","BK4532","IE0002141913.USD","LU0205194284.USD","LU1829250122.USD","LU0320765489.SGD","MEDX","LU1863844665.USD","LU0240877869.USD","BK4534","BK4585","BK4549","LU0205193047.USD","IE00B2B36J28.USD","NVS","MTCH","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4588","IE0034235071.USD","LU0211331839.USD","BK4007","IE00BFTCPJ56.SGD","BK4508","UBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148610163","title":"US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1148610163","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148610163?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:00","pubTimestamp":1788271219,"startTime":"0","endTime":"0","summary":"On Tuesday, shares of Novartis AG (NVS.US) climbed more than 5% to trade at $160.82 apiece. The surge follows the company's announcement that its investigational oral therapy, remibrutinib, met key...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","LU0320765489.SGD","BK4532","01477","BK4585","IE00B4R5TH58.HKD","LU0211331839.USD","BK1191","LU0070302665.USD","PPH","BK4007","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0208291251.USD","MEDX","NVS","BK4588","BK1574","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485406","title":"Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485406?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:54","pubTimestamp":1788270840,"startTime":"0","endTime":"0","summary":"Novartis AG Sponsored ADR  is currently at $160.98, up $8.92 or 5.87%--Would be highest close since March 10, 2026, when it closed at $161.59--On pace for largest percent increase since March 27, 2023, when it rose 8%--Snaps a four day losing streak--Up 16.76% year-to-date--Down 4.53% from its all-time closing high of $168.62 on Feb. 27, 2026--Up 27.12% from 52 weeks ago , when it closed at $126.64--Down 4.53% from its 52-week closing high of $168.62 on Feb. 27, 2026--Up 32.17% from its 52-week closing low of $121.80 on Oct. 29, 2025--Traded as high as $163.57; highest intraday level since March 4, 2026, when it hit $165.69--Up 7.57% at today's intraday high; largest intraday percent increase since March 27, 2023, when it rose as much as 8.37%All data as of 9:52:05 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0211331839.USD","IE00BFTCPJ56.SGD","BK4578","LU0320765489.SGD","MEDX","BK4588","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","PPH","NVS","IE00BJJMRZ35.SGD","LU0070302665.USD","IE0009355771.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664285481","title":"Sector Update: Healthcare Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664285481?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:17","pubTimestamp":1788268638,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) down 0.5%Novartis (NVS) shares were up ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0072461881.USD","LU0211326755.USD","LU2271345857.HKD","IE00B42XCP33.USD","IE0009355771.USD","BK4532","IE00B2B36J28.USD","LU0158827781.USD","LU0314106906.USD","LU1116320901.HKD","LU1061106388.HKD","LU1023059063.AUD","LU0106261372.USD","IE0002141913.USD","LU0496365809.HKD","IE00B4R5TH58.HKD","LU1506573853.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","LU1989764664.SGD","IE00BGHQF631.EUR","LU1244550494.USD","IE00BDGV0183.EUR","NVS","IE00B3PB1722.GBP","LU2023251221.USD","MMED","LU1244550577.SGD","IE000M9KFDE8.USD","LU0320765489.SGD","LU2111349929.HKD","LU2112291526.USD","LU2468319806.SGD","LU0211331839.USD","LU1244550221.USD","LU0211326839.USD","XLV","IBB","PPH","BK4588","LU2089284900.SGD","HCSG","LU0070302665.USD","LU0432979614.USD","LU1983299246.USD","MEDX","MDT","XBI","LABU","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859859","title":"【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859859","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859859?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:01","pubTimestamp":1788264098,"startTime":"0","endTime":"0","summary":"TradingKey - On Tuesday (September 1) Eastern Time, futures on the three major U.S. stock indexes fell across the board in pre-market trading. Geopolitical risks escalated sharply after two supertankers were hit by unidentified projectiles in the Strait of Hormuz, driving international oil prices further up. Meanwhile, the global bond market sell-off persisted, pushing long-term government bond yields in major economies to multi-year highs and significantly dampening market risk appetite.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20240105/eb0f4a7f5f55ac405df7e752c6038bc8.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20240105/eb0f4a7f5f55ac405df7e752c6038bc8.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143844-us-pre-market-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INT","TSLA","LU1201861249.SGD","LU0079474960.USD","LU1815333072.USD","IE00BLSP4452.SGD","CMAG","LU2063271972.USD","LU2360106780.USD","BK4551","LU0511384066.AUD","LU2023250504.SGD","LU1261432733.SGD","MNRS","LU1429558221.USD","LU0251131958.USD","IE00BJJMRX11.SGD","GOOW","LU1267930730.SGD","LFGY","LU0476273544.USD","LU2242649171.HKD","LU1923622291.USD","LU1988902786.USD","TRFK","NVS","SG9999015341.SGD","IE00B2B36J28.USD","LU0477156953.USD","LU0006061336.USD","SKHYV","IE00BJJMRZ35.SGD","IE00BFSS7M15.SGD","LU2089985449.USD","LU2168563687.JPY","IE00B3T34201.USD","NVDS","BK4515","GOOP","LU0310800965.SGD","LU2462157665.USD","LU0240877869.USD","LU2237443382.USD","LU1043141396.HKD","LU2112291526.USD","LU2506951792.HKD","SNXX","LU1935042215.USD","LU0208291251.USD","BLCK","LU2023251221.USD","LU2491049909.HKD","LU0170899867.USD","09366","IE00B3PB1722.GBP","TSLW","LU0251142724.SGD","LU1242518931.SGD","LU0395794307.EUR","IE00B1XK9C88.USD","3NVD.UK","AGOX","GB00B4LPDJ14.GBP","LU0683600562.USD","LU2111349929.HKD","LU0965509101.SGD","IE00B4YYXB79.USD","LU1400636574.HKD","LU1868837300.USD","IE00B1BXHZ80.USD","LU2361044949.HKD","LU2272731600.USD","LU1119994496.HKD","PTF","GOOY","IE00BVYPNW00.USD","07366","IE00B19Z3581.USD","LU0061474960.USD","LU0314104364.USD","IE000YTNTUN2.SGD","LU1670628061.USD","IE000W1ABFV2.USD","LU1934455194.USD","LU2168564149.EUR","LU0345774391.USD","LU0426417589.USD","LU0321505439.SGD","BK4532","LU1839511570.USD","LU2746668461.USD","GOGL","LU0215105999.USD","NVDU","PPH","WDC","LU2264538146.SGD","LU2756315664.SGD","LU0072462426.USD","LU2360032135.SGD","IE0034235303.USD","BK4592","LU1894683348.USD","BK4600","BK4581","CHPS","SGXZ81514606.USD","BK4604","IE00BYXW3230.USD","LU0080751232.USD","LU0528227936.USD","BK4614","LU1069347547.HKD","LU2089984988.USD","LU2420271590.USD","LU2458330169.SGD","PALD","SG9999014567.USD","TSLY","TRUC","LU0097036916.USD","LU0070217475.USD","QCML","LU0256863902.USD","TSLO","HUT","LU1400636657.SGD","SG9999015978.USD","IE00BJJMRY28.SGD","TSLG","LU0648000940.SGD","LU2097344357.USD","LU0289960550.SGD","LU1992135472.HKD","SG9999002224.SGD","BK4514","CLSE","IE00BJT1NW94.SGD","LU2322448957.HKD","IE00BJTD4V19.USD","TSYY","LU0081259029.USD","07388","IE00BWXC8680.SGD","04335","CHAT","LU0321505868.SGD","LU1043141123.HKD","CRSH","LU2097829019.USD","LU2931357623.SGD","SNDQ","IE00BQXX3F31.USD","TTEQ","VOX","LU1861215975.USD","MUU","BK4573","LU1244550577.SGD","LU2148611432.USD","LU0128525929.USD","LU2125154778.USD","LU1127390331.HKD","LU0820562030.AUD","LU3102509885.SGD","SOXY","LU0149725797.USD","GAMR","INTC","LU1069344957.HKD","IE0034235188.USD","LU2361045086.USD","TSLR","SGXZ80539844.SGD","LU1712237335.SGD","LU0096362180.USD","HK0000532082.HKD","LU1868836757.USD","ROM","XLC","TSLT","SG9999014575.USD","LU1585245621.USD","IE0004091025.USD","NVD3.UK","GOU","IETC","IE00BK4W5M84.HKD","LU2065171311.SGD","ABFL","LU0053666078.USD","IE00BVYPNQ40.USD","LU1861127337.USD","NVDL","LU1951200564.SGD","TYLG","LU0251132253.USD","NVD2.UK","LU2191332357.HKD","LU2048586759.USD","BK4554","LU1506573853.SGD","IE00B3SWFQ91.USD","GOOX","IE00BN29S564.USD","LU0158827781.USD","LU0823413587.USD","LU0965508806.USD","BK4560","HK0000320264.USD","LU2417539215.USD","LU1989764748.USD","IE00B5949003.HKD","LU2462591277.SGD","SNVD.UK","LU0672654240.SGD","MRVU","SKDD","2NVD.UK","LU1221951129.SGD","LU1633808545.USD","LU1670756490.USD","IE0004445239.USD","IE00BFSS8Q28.SGD","SG9999015986.USD","METV","LU1121112475.USD","SG9999014898.SGD","LU2098885051.SGD","IE00BVYPNP33.GBP","LU0689626769.HKD","NULC","LU0265550359.USD","PANG","BK4575","LU2286300806.USD","TESL","LU0109391861.USD","IE00BK4W5L77.USD","HK0000306685.HKD","LU0157215616.USD","LU2452424414.USD","LU2210150020.SGD","LU1935042488.USD","LU0345770993.USD","LU0130102774.USD","LU1815336760.USD","LU2543165471.USD","SG9999000418.SGD","IE00B7KXQ091.USD","BK4512","LU2764262908.HKD","USXF","LU1244550221.USD","IE00BLSP4239.USD","COWG","LU1153585028.USD","LU2237443622.USD","AIFD","LU1868837136.USD","LU0823421333.USD","FXL","IE00BD6J9T35.USD","LU0154236417.USD","OGIG","SPTE","LU2461242641.AUD","MEDX","BK4576","LU0868494708.USD","LU2077746001.SGD","LU2413666699.HKD","TLA","TSLS","LU2244417387.USD","LU0985320562.USD","LU2083900584.USD","BK4141","LU0210533765.USD","LU2322448791.USD","BK4533","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","QQQG","LU2168564222.USD","SG9999014880.SGD","LU0820561909.HKD","LU2213496289.HKD","GPRO","NVDQ","SMH","IE000MB6IJN5.SGD","SKHN","LU2272731782.SGD","LU0889566641.SGD","LU2456880835.USD","NVDA","SKHX","WDCC","LU2087625088.SGD","SOXQ","LU0432979614.USD","SG9999015945.SGD","LU1868836591.USD","BUG","LU0082616367.USD","LU0320765489.SGD","LU0312595415.SGD","LU2125909593.SGD","LU2552382058.USD","BK4548","LU1291159041.SGD","IE00BKPKM429.USD","CNAV","EFIV","AIPI","LU2237443978.SGD","LU1084165304.USD","LU0143551892.USD","SK","TSLQ","LU1496350171.SGD","LU2247934214.USD","LU0203201768.USD","LU0557290698.USD","IE00BN8TJ469.HKD","NVDO","LU2106854487.HKD","LU0225283273.USD","QCOM","DRMY","LU0289961442.SGD","EGGY","LU1169590202.USD","IE000M9KFDE8.USD","DELL","LU1551013342.USD","FDRV","THMR","LU2764263039.SGD","HK0000306701.USD","IDRV","ELOL","LU2210149790.SGD","IE00B19Z8W00.USD","QQQA","LU0738911758.USD","LU0029864427.USD","LU0211326755.USD","LU1732800096.USD","SG9999017495.SGD","LU2065169927.USD","LU0979878070.USD","LU2362541273.HKD","CGGO","IE00B3S45H60.SGD","LU0648001328.SGD","DLLL","IE000ITXATA3.USD","LU0158827948.USD","LU2108987350.USD","LU0965509283.SGD","LU1430594728.SGD","BK4007","NVD","BK4535","IE00BQXX3C00.GBP","IE000WAW04H5.SGD","LU2089283258.USD","LU2237443465.HKD","PANW","BK4511","IE0000B7K699.USD","LU1721428933.USD","BK4553","IHAK","IE0004445015.USD","WATS","LU1699723380.USD","DIPS","LU2592432038.USD","IE00B3M56506.USD","LU1244550494.USD","BK4538","LU0128525689.USD","LU2265009873.SGD","LU0061475181.USD","LU0640476718.USD","TESC","IE00BMPRXN33.USD","NVDG","TSII","LU0690374961.EUR","LU0889565833.HKD","LU1035773651.USD","LU0719512351.SGD","LU0472753341.HKD","LU1366192091.USD","LU0348723411.USD","LU1989771016.USD","LU1992135399.USD","LU1169589451.USD","LU2250418816.HKD","PALU","LU1145028129.USD","07788","LU0072461881.USD","LU1868836914.USD","LU0175139822.USD","BK4550","LU0642271901.SGD","IE00BFMHRM44.USD","LU0949170772.SGD","LU2954938101.SGD","BK4534","IE0002270589.USD","BK4598","LU0323591593.USD","LU0949170426.SGD","IE00BJLML261.HKD","IE0001KFT4U8.USD","IGV","LU0477156797.USD","IXN","SNVDAmain","LU2430703251.USD","LU1629891620.HKD","CNEQ","PSI","RULE","SMOG","BK4574","BK4602","HBMX","LU0786609619.USD","LU0162691827.USD","SGXZ99366536.SGD","IE00BHPRN162.USD","LU1935043536.SGD","LU0124676726.USD","LU1267930813.SGD","LU2125909759.SGD","HK0000819398.USD","LU1267930227.SGD","IE00BJTD4N35.SGD","LU0345770308.USD","BK4097","LU2764263203.CNY","LU2095319765.USD","ESLG","CHPX","LU2430703095.HKD","GB00BDT5M118.USD","LU0070302665.USD","BK4516","LU1301847155.USD","IE000SO60NU8.SGD","LU0787776722.HKD","LU2237443549.SGD","IE00BVYPNV92.GBP","BK4082","LU0316494557.USD","LU2355687059.USD","SKYY","LU0240878834.USD","LU0130518102.USD","LTL","HK0000304797.USD","IE0034235295.USD","LU0203202063.USD","BK4595","LU2168564065.EUR","LU1548497426.USD","LU0689472784.USD","IE0009G5SDU7.USD","LU1303367103.USD","LU0496365809.HKD","LU0133085943.USD","LU0820561818.USD","SG9999015358.SGD","LU1035775433.USD","LU0052756011.USD","LU2357627491.SGD","LU2237957902.USD","LU2100268510.USD","BK4023","LU2271345857.HKD","LU2102340556.USD","JGRO","BK4612","LU1116320901.HKD","IE00B7SZLL34.SGD","LU0795875086.SGD","LU0054578231.USD","PSWD","HK0000320223.HKD","LU2326559502.SGD","XNTK","LU0964807845.USD","IE0002141913.USD","LU0882574139.USD","SINTCmain","LU2357305700.SGD","GOOGL","IE00BDRTCR15.USD","LU2552382132.HKD","LU0965509010.AUD","LU0138981039.USD","09766","QCMD","IE00BQXX3D17.EUR","LU2237443895.HKD","LU0048573561.USD","IE0003U64NQ7.SGD","SNDC","LU2896262040.SGD","LU0203345920.USD","SMU00main","LU1235294995.USD","LU1037948541.HKD","LU0320765059.SGD","LU0792757196.USD","LU2092627202.USD","LU2133065610.SGD","SG9999014542.SGD","LU1983260115.SGD","LU2505996681.GBP","WLDR","LU1066051498.USD","BK4561","LU1037948897.HKD","LU2237957811.SGD","LU2347655156.SGD","IE0009355771.USD","LU0823434740.USD","LU0302445910.USD","LU2756315318.SGD","VT","LU1718418525.SGD","SG9999015952.SGD","SKHA","LU1674673428.USD","LU1935043023.USD","LU2089284900.SGD","ILDR","LU2236285917.USD","LU0444971666.USD","USD","VGT","BK4588","LU0323239441.USD","LU0354030438.USD","LU0859254822.USD","LU1046421795.USD","NVYY","LU1983299246.USD","BK4078","IE00B5TLWC47.USD","LU0708995401.HKD","LU0006306889.USD","LU1979441026.SGD","LU2294711713.HKD","TSLL","TSLZ","LU0784385840.USD","LU2602419157.SGD","LU0109392836.USD","SHOC","LU0976567544.SGD","LU0353189680.USD","BK4605","LU0823397103.USD","LU0011850046.USD","LU1823568750.SGD","LU2381873111.SGD","AIQ","ARTY","FTXL","LU0943347566.SGD","LU0795875169.SGD","GGLS","GOOL","LU0069063385.USD","LU1242518857.USD","FSMD","LU0823413660.USD","LU2403377893.USD","LU1221951046.USD","HK0000914686.HKD","LU0266013472.USD","LU2552382215.SGD","MUYY","IE00BFTCPJ56.SGD","SG9999002232.USD","BK4585","IE00BDCRKT87.USD","NVDX","LU1201861165.SGD","LU2097344431.USD","SG9999018857.SGD","NVIW.SI","LU2505996509.AUD","LU0784383803.USD","LU1059921491.USD","LU2028103732.USD","FCOM","LU0211331839.USD","LU0107464264.USD","LU1914381329.SGD","BK4608","ANV","SGXZ23171101.USD","NVDB","LU2054465674.USD","SPAM","LU0661504455.SGD","LU0238689110.USD","STSLAmain","LU2065170008.USD","LU0174119429.USD","IE00BSNM7G36.USD","LU2125909247.SGD","BK4587","LU1670627923.USD","LU1232071149.USD","TDV","LU0823397285.USD","LU0823411888.USD","LU1935042991.SGD","SGXZ44715902.SGD","LU2361044865.SGD","LU0690374615.EUR","LU0942090050.USD","LU1934455277.USD","SKHY","09388","LU2211815571.USD","HK0000304805.HKD","LU1989772923.USD","LU0057025933.USD","WDCX","LU2491050154.USD","LU1974910355.USD","LU0289739343.SGD","LU1861558580.USD","MVLL","LU0256863811.USD","LU2860962120.EUR","LU0265550946.USD","MDT","LU2357125470.USD","LU0426412945.USD","LU2468319806.SGD","SOXX","LU0784384876.USD","LU0912757837.SGD","LU0106261372.USD","LU1023059063.AUD","LU1623119135.USD","LU1003077747.HKD","LU2471134952.CNY","IE00BKDWB100.SGD","LINT","LU0957808578.USD","MUZ","NVDD","BK4549","IE00BKVL7J92.USD","LU0345774631.USD","LU2471134879.HKD","MUD","SG9999014906.USD","SQCOMmain","LU0127658192.USD","LU1880398554.USD","NVII","QCMU","INTW","INYY","LU0708994859.HKD","LU0122379950.USD","LU1791710582.SGD","BK4529","LU2491050071.SGD","LU0210528500.USD","IE00BZ199S13.USD","LU0314106906.USD","LU1778281490.HKD","LU1804176565.USD","IE000BZT7R73.USD","LU2347655073.USD","TTXU","IE0004086264.USD","TMSL","LU0788109477.HKD","LU1066051225.USD","LU2023250330.USD","FCUS","NVDS.UK","LU0444973449.USD","CLOD","LU2249611893.SGD","LU1956131251.USD","LU0310800379.SGD","LU2272731865.HKD","LU2463028550.USD","MRVX","LU1323610961.USD","LU0276348264.USD","LU1144417596.USD","LU2430703178.SGD","LIT","LU1923623000.USD","MIC","SG9999004303.SGD","SKUU","GB00B4QBRK32.GBP","IE00B19Z8X17.USD","FAI","BK4555","LU0234570918.USD","LU0823414478.USD","LU2065171402.SGD","LU1880398471.USD","NVDW","MU","LU0267386448.USD","LU0742534661.SGD","LU1366333091.USD","IE00BDGV0183.EUR","LU0210536198.USD","LU0310799852.SGD","HYNX","LU2023250843.SGD","SCHA","LU2720916845.USD","IE000Q6AESB8.SGD","IE00B775H168.HKD","LU0094547139.USD","LU0211328371.USD","LU2168564495.EUR","BK4578","LU2360107168.USD","IE00BGHQF631.EUR","LU1951198990.SGD","LU0823434583.USD","AIS","LU0048584097.USD","IE00B19Z9505.USD","LU0077335932.USD","LU0980610538.SGD","SKHZ","LU1894683264.USD","WCLD","NVC","SMHX","LU1803068623.USD","WISE","BK4543","LU1821325948.USD","LU2242650005.HKD","LU0345769128.USD","IE00BFXG1179.USD","LU1923622614.USD","EMSF","LU1496350502.SGD","LU1057294990.SGD","LU0347712357.USD","LU0861579265.USD","LU2750360641.GBP","LU2487616109.SGD","LU0494093205.USD","LU0994945656.USD","WANT","LU0784385170.HKD","LU1803068979.SGD","HAKY","LU0390134368.USD","LU1196500208.SGD","LU2279689827.SGD","LU0187121727.USD","LU0823421416.USD","LU1642822529.SGD","LU2125909916.SGD","LU0724617625.USD","LU1202635105.USD","LU2433249047.HKD","IE00BGHQDM52.EUR","LU0726765562.USD","LU0545039389.USD","LU0308772762.SGD","LU0823414551.USD","LU1791710400.SGD","IE00BMPRXQ63.HKD","LU1066051811.HKD","SNDU","LEGR","SNPE","DTCR","IE000F7OJYX1.SGD","IE00BBT3K403.USD","LU1814569148.SGD","LU2275660780.HKD","LU1720051108.HKD","SCHM","SG9999001424.SGD","IE00B775SV38.USD","FDTX","LU0203347892.USD","IE0005OL40V9.USD","BK4527","HUTG","LU0345769631.USD","FTEC","LU0868494617.USD","LU0957791311.USD","LU0096364046.USD","LU2458330243.SGD","LU2394011477.USD","SG9999014559.SGD","LU0211326839.USD","BK4566","BOBP","LU0198837287.USD","LU1267930573.SGD","LU2087621335.USD","TSL","BK4170","IE0009356076.USD","LU2125154935.USD","MULL","BK4503","LU1861220033.SGD","MRVL","BAI","XLK","LU0234572021.USD","LU2471134796.USD","LU2404859741.USD","LU0417517546.SGD","LU0056508442.USD","LU1551013425.SGD","LU2473716301.USD","GXPC","BK4077","CIBR","LU1732799900.SGD","LU1316542783.SGD","HK0000914660.USD","LU1934455863.HKD","LU0466842654.USD","LU2750360997.AUD","LU0345768153.USD","TEK","LU2637965513.SGD","LU2413666426.HKD","LU2999663052.SGD","SG9999014914.USD","BK4567","LU2092937148.SGD","LU1280957306.USD","SGXZ31699556.SGD","LU2462591350.SGD","GTEK","WCBR","LU2047632596.USD","MUG","SGXZ51526630.SGD","TSDD","LU2237438978.USD","LU1116320737.USD","LU0354030511.USD","LU0345768740.USD","LU1400636491.USD","LU1989764664.SGD","LU0342679015.USD","LU2404859667.USD","CQTM","IE00BZ1G4Q59.USD","LU1720051017.SGD","09788","BK4099","IE000KEQY171.SGD","WUGI","LU1435385759.SGD","LU1645745479.HKD","LU1061106388.HKD","LU1571399168.USD","LU1917777945.USD","SKHL","TSLI","XDAT","BK4579","LU2746668974.SGD","TEST","LU0274383776.USD","07766","GGLL","NVDY","LU2362541513.USD","IE00B42XCP33.USD","LU0130517989.USD","SNDK","LU1861559042.SGD","LU0130103400.USD","LU1852331112.SGD","LU0553294199.USD","IE00B4JS1V06.HKD","SKHU","LU1066053197.SGD","OPTZ","LU1032955483.USD","LU2362540622.SGD","LU0061474705.USD","LU0353189763.USD","LU0963586101.USD","TSLP","LU1989772840.SGD","ESUM","LU1267930490.SGD","SNDG","LU0211327993.USD","LU1691799644.USD","DISK","LU0323240290.USD","07709","SG9999018865.SGD","LU1064131342.USD","LU2471134523.USD","LU1674673691.USD","IE00BMPRXR70.SGD","DRIV","LU2290526834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU0553294199.USD","LU0820561909.HKD","IE00BSNM7G36.USD","LU0096364046.USD","LU1883839398.USD","LU0154236417.USD","LU0471298694.HKD","LU0225284248.USD","LU0225283273.USD","LU1059921491.USD","OZEM","LU0234570918.USD","LU0310800379.SGD","LU2750360641.GBP","SG9999014567.USD","LU2133065610.SGD","LU1699723380.USD","LU0345770308.USD","LU0980610538.SGD","LU0029864427.USD","LU1989771016.USD","BK4533","BK4592","LU1934455194.USD","IE0001KFT4U8.USD","LU0861579265.USD","LU1691799644.USD","LU0198837287.USD","LU0058720904.USD","LU0787776722.HKD","IE000F7OJYX1.SGD","LU2028103732.USD","LU2361045086.USD","LU1032955483.USD","LU0130517989.USD","LU0210528500.USD","LU0985320562.USD","PFE","FTXH","LU2023250330.USD","LU2271345857.HKD","LU0965509101.SGD","LU0889565916.HKD","LU0225771236.USD","LU2168564222.USD","IE0034235303.USD","LU1674673428.USD","SG9999015986.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU0726765562.USD","LU0109394709.USD","LU1718418525.SGD","LU2505996681.GBP","IE00BVYPNV92.GBP","LU1894683348.USD","ELIS","SG9999018857.SGD","SGXZ31699556.SGD","IE00BN8TJ469.HKD","IE00BFXG1179.USD","IE0004445015.USD","IXJ","LU0320765646.SGD","LU1236620750.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","IE0002270589.USD","LU0053666078.USD","LU0323591593.USD","LU0266013472.USD","AZNH","IBBQ","LU1548497426.USD","LU0320765489.SGD","GB00BDT5M118.USD","LU0661504455.SGD","LU1829250122.USD","LU0124676726.USD","LU1974910355.USD","BK7067","NVOH","LU2125154778.USD","LU1162221912.USD","LU0466842654.USD","SG9999014906.USD","LU2491049909.HKD","LU1585245621.USD","SG9999015341.SGD","LU2746668974.SGD","IE00B4JS1V06.HKD","LLYX","SG9999017495.SGD","GDOC","JDOC","SG9999002232.USD","SG9999014559.SGD","LU0994945656.USD","SG9999015945.SGD","IE000WAW04H5.SGD","IE00BFTCPJ56.SGD","LU1221951046.USD","LU1670711123.USD","LU1868836757.USD","LU1366192091.USD","LU2896262040.SGD","LU1988902786.USD","LU1868836914.USD","LU2089283258.USD","LU2089284900.SGD","BK4585","LU1934455277.USD","IE00B775H168.HKD","LU1280957306.USD","LU1244550494.USD","IE000BZT7R73.USD","LU0795875169.SGD","LU1629891620.HKD","SG9999002224.SGD","LU0345770993.USD","LU0511384066.AUD","LU0882574055.USD","LU1057294990.SGD","LU1116320901.HKD","LU2552382058.USD","JNJ","LU2087625088.SGD","LU0683600562.USD","LU0648001328.SGD","LU2125909593.SGD","LU2089984988.USD","LU1571399168.USD","BIB","LLY","IE00BVYPNW00.USD","LU0395794307.EUR","IE00B2B36J28.USD","LU2750360997.AUD","RXL","LU0256863902.USD","LU0006306889.USD","LU1267930813.SGD","LU0820562030.AUD","LU0289739343.SGD","LU1923622614.USD","LU2468319806.SGD","LU0321505868.SGD","LU0267386448.USD","LU0321505439.SGD","LU1868837136.USD","LU2242652126.USD","IE000MB6IJN5.SGD","LU2168564495.EUR","LU0265550946.USD","LU0061475181.USD","LU0965508806.USD","04332","BK4578","LU1069344957.HKD","LU1236620834.HKD","LU2746668461.USD","IE00B19Z3581.USD","LLYZ","LU2237443622.USD","LU0417517546.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0170899867.USD","IE00BBT3K403.USD","LU2487616109.SGD","LU1670710661.SGD","ELIL","LU1934455863.HKD","IE00BJJMRX11.SGD","LU2461242641.AUD","LU0432979614.USD","LU1551013425.SGD","LU0965509010.AUD","AMGN","LU0265550359.USD","SGXZ81514606.USD","IE000M9KFDE8.USD","IE0009355771.USD","LU0162691827.USD","LU1066051225.USD","REGN","IE00BJLML261.HKD","BBIO","LU2347655156.SGD","BK4550","ABBV","LU0316494557.USD","NVOX","SG9999014914.USD","LU2129689605.HKD","LU0859254822.USD","LU1023059063.AUD","LU1670711040.USD","LU1670628061.USD","LU1074936037.SGD","LU2471134796.USD","LU1127390331.HKD","IE000SO60NU8.SGD","SG9999013999.USD","LU2023251221.USD","IE00BDGV0183.EUR","LU1804176565.USD","LU1228905540.USD","GLAM","LU2347655073.USD","LU1116320737.USD","SG9999014575.USD","LU2602419157.SGD","LU1003077747.HKD","LU2756315318.SGD","AZN","LU2063271972.USD","IE00BN29S564.USD","LU0211327993.USD","NVS","LU1929549753.HKD","LU1267930730.SGD","IE00B19Z3B42.SGD","IE00BJJMRY28.SGD","LU0238689110.USD","LU0689472784.USD","IE00BLSP4452.SGD","LU1623119135.USD","LU0098860793.USD","LU0882574139.USD","LU1868837300.USD","VHT","LU1093756325.SGD","LU1935042991.SGD","PAWZ","LU1043141396.HKD","LU0097036916.USD","SGXZ57979304.SGD","LU2596442595.SGD","LU1066051811.HKD","LU0545562505.USD","LU1032466523.USD","LU1732799900.SGD","LU1989772923.USD","SG9999014542.SGD","LU0385154629.USD","CSL.AU","LU0109391861.USD","BK4568","LU0545039389.USD","LU0094547139.USD","AGNG","LU0345769631.USD","LU0472753341.HKD","LU0203345920.USD","LU0456855351.SGD","IE0002141913.USD","LU0203201768.USD","BK4007","LU2462157665.USD","LU1989772840.SGD","BK4566","LU2430703178.SGD","IE00BK4W5L77.USD","BK4588","LU1221951129.SGD","BMY","MEDX","LU0943347566.SGD","LU0203202063.USD","LU1551013342.USD","06160","GSK","IE00BKVL7J92.USD","LU1983299246.USD","PJP","LU0345769128.USD","LU1430594728.SGD","688235","GSKH","BK4504","BK4581","LU1061106388.HKD","LU0106261372.USD","LU0868494617.USD","LU2361044865.SGD","LU0211331839.USD","LU0426417589.USD","SG9999015978.USD","SGXZ99366536.SGD","LU0289961442.SGD","LU0203347892.USD","LU2552382215.SGD","LU2471134879.HKD","LU0237698245.USD","LU0158827948.USD","LU2236285917.USD","LU0320765992.SGD","LU2756315664.SGD","LU1066053197.SGD","LU2125909247.SGD","NVO","LU1201861249.SGD","LU0792757196.USD","LU0353189763.USD","LU0310799852.SGD","LU2430703095.HKD","LU2108987350.USD","LU2237443382.USD","LU1323610961.USD","LU1712237335.SGD","LU2552382132.HKD","GILD","LU1066051498.USD","LU2211815571.USD","LU0640476718.USD","LU0354030438.USD","SG9999003800.SGD","IE00BWXC8680.SGD","LU0306806265.USD","SGXZ80539844.SGD","LU2491050154.USD","MHIP","ONC","LU2242646821.SGD","LU2087621335.USD","SG9999001440.SGD","LU1670710588.SGD","LU1979441026.SGD","LU0985481810.HKD","IE00B4R5TH58.HKD","MEDI","BK4534","LU1196500208.SGD","LU2168563687.JPY","THNR","TBXU","IE00B1XK9C88.USD","LU0738911758.USD","LU0889566641.SGD","IE00BGHQF631.EUR","IE00B7SZLL34.SGD","LU2360032135.SGD","IE00BFSS8Q28.SGD","BK7511","LU0234572021.USD","LU2237438978.USD","LU1670627923.USD","LU0795875086.SGD","LU0128525929.USD","LU2168564065.EUR","SG9999011175.SGD","CANC","IE00BKDWB100.SGD","BBH","LU2433249047.HKD","LU0256863811.USD","LU2264538146.SGD","LU1035775433.USD","LU2125154935.USD","BK0239","LU0070217475.USD","LU1035773651.USD","LU1244550221.USD","LU2462591350.SGD","LU0823416689.USD","IE00B42XCP33.USD","LU1496350171.SGD","LU2403377893.USD","IE0005OL40V9.USD","LU0965509283.SGD","LU1069347547.HKD","LU0057025933.USD","HRTS","LU1267930573.SGD","SG9999001176.USD","BK4516","LU0158827781.USD","LLII","IE00B3T34201.USD","LU2237443895.HKD","LU0708994859.HKD","LU0289739699.SGD","BK4559","LU0672654240.SGD","LU1244550577.SGD","LU1291159041.SGD","IBB","XLV","BK4532","LU0070302665.USD","LU0211328371.USD","LU0320765059.SGD","FHLC","IE00BFSS7M15.SGD","LU1261432733.SGD","BK4599","LU2129689514.USD","SG9999001176.SGD","LU1093756168.USD","LU0823434583.USD","LU0868494708.USD","LU2237443978.SGD","LU0174119429.USD","GSK.UK","LU1064131342.USD","LU1732800096.USD","LU0823434740.USD","SGXZ51526630.SGD","LU1917777945.USD","LU0072461881.USD","LU0942090050.USD","WDNA","LU1267930490.SGD","LU2213496289.HKD","MRK","LU1941712264.USD","LU0133085943.USD","CURE","LU2111349929.HKD","SG9999014880.SGD","LU2417539215.USD","BK4583","LU0306807586.USD","LU0786609619.USD","SG9999014898.SGD","LU1496350502.SGD","LU0130102774.USD","LU2471134952.CNY","LU1121112475.USD","LU2592432038.USD","LU2265009873.SGD","LU0210536198.USD","LU1720051017.SGD","LU1232071149.USD","LU2471134523.USD","LU0689626769.HKD","LU1868836591.USD","LU2129689431.USD","LU1814569148.SGD","LU2237443549.SGD","IE0000B7K699.USD","BMED","ILDR","LU1037948897.HKD","PBE","LU2023250504.SGD","LU2324357040.USD","LU2237443465.HKD","LU1941712348.USD","LU0964807845.USD","SG9999015952.SGD","LU2357305700.SGD","LU1839511570.USD","LU0949170772.SGD","TRUH","LU0114720955.EUR","LU2360106947.USD","BK7501","IE00BJJMRZ35.SGD","IE0004445239.USD","LU0912757837.SGD","LU2362541273.HKD","LU0069063385.USD","LU1778281490.HKD","LU0353189680.USD","LU1674673691.USD","LU2430703251.USD","IE00BJT1NW94.SGD","LU2362540622.SGD","IE00B1BXHZ80.USD","LU2456880835.USD","SG9999018865.SGD","LU0208291251.USD","LU1506573853.SGD","BK4139","LU1720051108.HKD","IE00BKPKM429.USD","LU0122379950.USD","IE00B3PB1722.GBP","LU2505996509.AUD","TMED","IE00BLSP4239.USD","IYH","LU1228905037.USD","LU0079474960.USD","LU0471298777.SGD","LU0820561818.USD","IE00B7KXQ091.USD","LU2357627491.SGD","LU1894683264.USD","LU0354030511.USD","BK4505","LU1145028129.USD","LU2361044949.HKD","LU2362541513.USD","LU2168564149.EUR","LU1043141123.HKD","LU2491050071.SGD","LU1914381329.SGD","NVOC","IHE","BK7508","PPH","LU2023250843.SGD","LU0426412945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855406","title":"Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855406?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:34","pubTimestamp":1788262440,"startTime":"0","endTime":"0","summary":"Novartis released a mixed bag of clinical updates, pausing trials for one drug after a spate of patient deaths while simultaneously revealing positive data for a pill that analysts view as a potential","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","LU0208291251.USD","BK4532","PPH","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4007","IE0002141913.USD","IE00B4R5TH58.HKD","BK4588","NVS","BK4585","BK4578","LU0320765489.SGD","LU0070302665.USD","IE00BJJMRZ35.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853221","title":"NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853221","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853221?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:02","pubTimestamp":1788260532,"startTime":"0","endTime":"0","summary":"NetraMark appoints Abivax regulatory chief Keith Fournier to boardNetraMark appointed pharmaceutical executive Dr. Keith M. Fournier to its board.Fournier is senior vice president and head of regulato","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL1PTSTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU2129689514.USD","AZN.UK","LU1670627923.USD","BK4566","LU2433249047.HKD","03165","JDOC","LU2091194634.USD","IE00BQXX3F31.USD","PJP","PPH","TRUH","LU0128525689.USD","ABBV","LU0823399737.USD","LU0868494617.USD","XLV","IE00BQXX3C00.GBP","IYH","LU1023059063.AUD","LU0868494708.USD","LU2357627491.SGD","LU0887340254.USD","LU0345777147.USD","IXJ","LU0526926950.USD","LU2089284900.SGD","NDAQ","AGNG","LU1061106388.HKD","BCDF","LU2089984988.USD","LU0170899867.USD","LU1496350502.SGD","MEDX","LU2347655073.USD","LU1989772840.SGD","FHLC","FTXH","LU0171276677.USD","LU0965509010.AUD","GLAM","IE00B64PRP62.GBP","VHT","LU0949170426.SGD","LU1153584641.USD","RXL","LU1236620834.HKD","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853142","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853142?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:50","pubTimestamp":1788259807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134796.USD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0106261372.USD","LU0943347566.SGD","LU1979441026.SGD","LU2089984988.USD","LU0882574139.USD","LU0823434583.USD","SGXZ81514606.USD","SG9999014914.USD","OZEM","LU2361044949.HKD","LU2468319806.SGD","BK4588","LU2461242641.AUD","LU2168564222.USD","LU0234572021.USD","LU2462591350.SGD","LU1974910355.USD","LU2237438978.USD","LU2552382058.USD","LU2237443622.USD","LU2271345857.HKD","LU2750360641.GBP","LLY","LU2236285917.USD","LU0256863811.USD","LU2168563687.JPY","LU0058720904.USD","IE00BKPKM429.USD","GDOC","LU1267930730.SGD","LU2211815571.USD","LU0079474960.USD","HRTS","LU1720051108.HKD","LU2264538146.SGD","TRUH","LU0158827948.USD","LU2324357040.USD","LU2028103732.USD","IE00BK4W5L77.USD","BK4139","LU0316494557.USD","IE0004445015.USD","LU0683600562.USD","SG9999014906.USD","LU2111349929.HKD","IXJ","LU0672654240.SGD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","LU1035775433.USD","SGXZ51526630.SGD","LU0353189763.USD","LU0889565916.HKD","PJP","GB00BDT5M118.USD","LU2023251221.USD","SG9999018865.SGD","LU2087625088.SGD","LU0385154629.USD","LU1548497426.USD","LU0708995401.HKD","LU0266013472.USD","LU2168564495.EUR","IE0001KFT4U8.USD","LU0203201768.USD","LU0323591593.USD","LU0882574055.USD","LU1868836914.USD","LU2756315318.SGD","LU1917777945.USD","LU1551013425.SGD","LU1623119135.USD","LU1064131342.USD","LU1023059063.AUD","LU2063271972.USD","BK4007","LU2471134952.CNY","LU1868837300.USD","LU2357305700.SGD","LU1629891620.HKD","IE0002141913.USD","LU2361045086.USD","LU2361044865.SGD","IE00BJLML261.HKD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","LU1989771016.USD","FTXH","LU0820562030.AUD","LU1057294990.SGD","PPH","LLYZ","LU2237443465.HKD","LU0471298777.SGD","ELIS","IE00BJJMRZ35.SGD","LU0238689110.USD","LU0320765059.SGD","LU2237443382.USD","IE00B1BXHZ80.USD","LU1988902786.USD","IMUX","SG9999014880.SGD","LU1145028129.USD","LU0640476718.USD","SG9999013999.USD","LU2552382132.HKD","LU0096364046.USD","LU1868837136.USD","LU0823416689.USD","SG9999018857.SGD","BK4534","LU2112291526.USD","LU2602419157.SGD","JDOC","LU0109391861.USD","LU2237443978.SGD","WDNA","LU1868836757.USD","LU1069344957.HKD","LU2023250330.USD","LU2746668461.USD","IE00BN29S564.USD","LU2491049909.HKD","LU0061475181.USD","FHLC","LLYX","LU1291159041.SGD","IE00B4R5TH58.HKD","LU2108987350.USD","LU0689472784.USD","SG9999015978.USD","LU1093756168.USD","CANC","LU0417517546.SGD","LU0320765992.SGD","LU0114720955.EUR","LU1804176565.USD","CURE","LU0353189680.USD","LU1366192091.USD","RXL","SG9999015945.SGD","LU2456880835.USD","LU2213496289.HKD","LU0820561818.USD","LU2491050071.SGD","LU0158827781.USD","LU0964807845.USD","IE00BFSS8Q28.SGD","LU0289739699.SGD","LU2471134879.HKD","BK4550","IE00BK4W5M84.HKD","LU0225283273.USD","IE0005OL40V9.USD","LU1323610961.USD","IDNA","LU2491050154.USD","IE00BKDWB100.SGD","LU2896262040.SGD","SG9999015986.USD","LU2746668974.SGD","LU1814569148.SGD","LU2237443895.HKD","SGXZ99366536.SGD","LU2462157665.USD","VHT","LU0256863902.USD","LU0432979614.USD","TMED","IE00B2B36J28.USD","LU2552382215.SGD","LU2360106947.USD","LU2023250504.SGD","LU2168564149.EUR","LU0471298694.HKD","LU0787776722.HKD","SGXZ57979304.SGD","LU0786609619.USD","LU2750360997.AUD","LU0466842654.USD","BK4532","LU0198837287.USD","LU0354030511.USD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","MEDI","SG9999001176.USD","LLII","SG9999015952.SGD","MEDX","LU0174119429.USD","LU1983299246.USD","LU2089283258.USD","BK4516","LU1868836591.USD","LU2471134523.USD","LU0345770993.USD","LU1093756325.SGD","SG9999001176.SGD","ELIL","BK4599","AGNG","LU2237443549.SGD","IYH","LU0456855351.SGD","LU2089284900.SGD","LU0094547139.USD","LU0354030438.USD","LU1280957306.USD","SG9999017495.SGD","IHE","LU1691799644.USD","LU0820561909.HKD","SG9999014898.SGD","LU2417539215.USD","IE00B775H168.HKD","LU1061106388.HKD","LU1720051017.SGD","LU2168564065.EUR","LU0109394709.USD","LU1551013342.USD","THNR","IE00BJJMRY28.SGD","LU0345770308.USD","BK4533","IE0009355771.USD","LU0133085943.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1232071149.USD","BK4581","LU0097036916.USD","LU2106854487.HKD","LU2265009873.SGD","LU0210536198.USD","IE00BJJMRX11.SGD","LU1712237335.SGD","INCY","LU0122379950.USD","LU0203202063.USD","LU2756315664.SGD","IE0004445239.USD","ILDR","BK4585","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664580608","title":"Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2664580608","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664580608?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:34","pubTimestamp":1788258840,"startTime":"0","endTime":"0","summary":"Novartis shares rose after the drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis, saying its new pill helped patients experience fewer flare-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE0002141913.USD","BK4578","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU0208291251.USD","IE00B2B36J28.USD","MEDX","BK4532","BK4585","LU0211331839.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","PPH","BK4588","LU0070302665.USD","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664580128","title":"Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2664580128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664580128?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258656,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced positive topline results from its Phase III Remodel-1/-2 trials of remibrutinib in relapsing multiple sclerosis. Remibruti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-results-from-phase-iii-remodel-1-2-trials-of-remibrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-results-from-phase-iii-remodel-1-2-trials-of-remibrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","BK4007","LU0211331839.USD","LU0070302665.USD","NVS","LU0320765489.SGD","IE0002141913.USD","BK4532","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0208291251.USD","MEDX","BK4588","BK4578","BK4585","PPH","IE00B2B36J28.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","BMED","IE00B2B36J28.USD","IE0002141913.USD","SYNB","TBXU","LU0211331839.USD","IBBQ","IE00BFTCPJ56.SGD","NVIB","PPH","BK4007","IE00B4R5TH58.HKD","LU0070302665.USD","HYLG","IE0009355771.USD","LU0208291251.USD","BK4588","CNCR","LFSC","IE00BJT1NW94.SGD","NVS","IBB","GDOC","BK4532","BK4585","FBT","GNOM","IE00BJJMRZ35.SGD","BK4578","MEDX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832960","title":"Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832960","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832960?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:54","pubTimestamp":1788252851,"startTime":"0","endTime":"0","summary":"Novo Nordisk launches Wegovy weight-loss pill in GermanyCOPENHAGEN, Sep 1 (Reuters)-Novo NordiskNOVOb.COhas launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44L0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4599","BK4007","NVO","LU1093756168.USD","NVOC","NVOH","BK4588","PPH","THNR","BK4532","OZEM","LU0154236417.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383293","title":"Novartis Says Remibrutinib Significantly Reduces Relapse Rates in Phase 3 Multiple Sclerosis Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383293","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383293?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:51","pubTimestamp":1788252718,"startTime":"0","endTime":"0","summary":"Novartis  said Tuesday that phase 3 trials of remibrutinib showed significantly reduced annualized relapse rates compared with teriflunomide in adults with relapsing multiple sclerosis.The trials met their primary endpoints and showed that remibrutinib was superior to teriflunomide on all key secondary measures.A preplanned combined analysis also showed a positive trend in three month confirmed disability progression and nominally significant results for six month confirmed disability progression, Novartis said.Remibrutinib also demonstrated a favorable safety profile with no liver safety signal, the company said.Novartis shares were over 4% higher in Tuesday premarket activity.Price: 158.47, Change: +6.41, Percent Change: +4.22","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765489.SGD","BK4007","IE00BJT1NW94.SGD","LU0070302665.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4585","NVS","IE00BFTCPJ56.SGD","BK4578","PPH","MEDX","BK4532","BK4588","IE00B2B36J28.USD","LU0208291251.USD","IE0009355771.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837891","title":"Eli Lilly (LLY) Eyes Merida Deal As Trial Data Strengthens Autoimmune Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837891","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837891?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:21","pubTimestamp":1788250894,"startTime":"0","endTime":"0","summary":"Eli Lilly (NYSE: LLY) plans to acquire Merida Biosciences to expand its autoimmune and allergic disease pipeline, including lead candidate MER511.\nThe deal is expected to add early stage precision immunology assets to Lilly's existing portfolio in metabolic and neurology treatments.\nNew Phase 3b TOGETHER trial data report durable 52 week efficacy for a Taltz and Zepbound combination in patients with psoriatic disease and obesity.\nThe dual therapy approach targets both psoriatic disease...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-eyes-merida-deal-as-trial-data-strengthens-aut","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-eyes-merida-deal-as-trial-data-strengthens-aut","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0174119429.USD","OZEM","LU2461242641.AUD","LU1291159041.SGD","TRUH","LU0158827948.USD","SG9999015952.SGD","LU2168564065.EUR","SG9999014880.SGD","LU1868837300.USD","LU2111349929.HKD","LU0345770308.USD","IE00BJLML261.HKD","LU2756315664.SGD","BK4533","LU0079474960.USD","LU1720051017.SGD","IE0004445239.USD","IE00BK4W5L77.USD","LU2023250504.SGD","LU2236285917.USD","LU2471134523.USD","LU1035775433.USD","LU0672654240.SGD","ILDR","LU1868836591.USD","LU0640476718.USD","SGXZ57979304.SGD","SG9999014914.USD","LU0289739699.SGD","SG9999014898.SGD","SG9999013999.USD","IE00BWXC8680.SGD","LU2168564222.USD","LU1069344957.HKD","LU2168564495.EUR","LU2417539215.USD","IHE","LU0203201768.USD","LU0106261372.USD","LU0354030438.USD","LU1551013425.SGD","LU0097036916.USD","LU1548497426.USD","LU0114720955.EUR","LU1093756325.SGD","HRTS","LU2089283258.USD","IE0009355771.USD","BK4599","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","LU2271345857.HKD","LU0820561818.USD","LU2746668974.SGD","LU2265009873.SGD","LU2237443465.HKD","LU2750360641.GBP","LU0385154629.USD","LU2552382132.HKD","LU0109391861.USD","BK4581","LU1366192091.USD","BK4588","SG9999015945.SGD","LU1712237335.SGD","LU1057294990.SGD","LU0225283273.USD","LU0353189680.USD","LU2237443382.USD","FTXH","LU2471134952.CNY","LU2237443895.HKD","LLYZ","XLV","LU0109394709.USD","LU0256863811.USD","LU1720051108.HKD","JDOC","LU1023059063.AUD","LU0471298777.SGD","LU2211815571.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU2361044949.HKD","LU0417517546.SGD","IE00B1BXHZ80.USD","IE00BFSS7M15.SGD","LU0943347566.SGD","LU0823434583.USD","LU2028103732.USD","LU2361045086.USD","LU0683600562.USD","LU0964807845.USD","LU2168564149.EUR","LU0820562030.AUD","LU1280957306.USD","GB00BDT5M118.USD","LU2361044865.SGD","LU2471134879.HKD","IE00B4JS1V06.HKD","LU0203202063.USD","LU1232071149.USD","LU1127390331.HKD","LU2087625088.SGD","LU0882574055.USD","LU2237443622.USD","LU0122379950.USD","LU1983299246.USD","LU2023250330.USD","TMED","PJP","LU2089284900.SGD","BK4007","LU2213496289.HKD","GDOC","IE00B1XK9C88.USD","LU2471134796.USD","LU2264538146.SGD","LU2552382215.SGD","LU2896262040.SGD","LLII","SG9999018857.SGD","LU2324357040.USD","LU0234572021.USD","SG9999018865.SGD","LU1979441026.SGD","LU1629891620.HKD","LU2491050071.SGD","VHT","IE00BK4W5M84.HKD","LU2750360997.AUD","RXL","SG9999001176.USD","LU1623119135.USD","LU1093756168.USD","SG9999017495.SGD","LU0198837287.USD","LU0266013472.USD","SGXZ99366536.SGD","LU1868837136.USD","IE00BJJMRY28.SGD","LU0256863902.USD","IE00B7KXQ091.USD","LU0820561909.HKD","LU0466842654.USD","LU2462591350.SGD","SG9999015978.USD","ELIS","BK4516","IE0001KFT4U8.USD","LU2237443549.SGD","BK4534","LU2112291526.USD","IE00BJJMRX11.SGD","LU0210536198.USD","LU0006306889.USD","IE0002141913.USD","LU0708995401.HKD","LU0061475181.USD","LU1145028129.USD","LU0689472784.USD","FHLC","LU1267930730.SGD","LU1551013342.USD","LU2237443978.SGD","PPH","LU1323610961.USD","LU0354030511.USD","LU2468319806.SGD","SG9999015986.USD","SGXZ81514606.USD","LU1989771016.USD","LU2360106947.USD","SG9999014906.USD","LU2237438978.USD","LU0096364046.USD","IXJ","LU2602419157.SGD","SGXZ31699556.SGD","LU0432979614.USD","LU0323591593.USD","LU2108987350.USD","IE00BKDWB100.SGD","IE00BN29S564.USD","AGNG","CURE","LU0316494557.USD","LU0823434740.USD","LU1974910355.USD","LU0158827781.USD","LU0823416689.USD","IE0005OL40V9.USD","LU2456880835.USD","LU2462157665.USD","LU2491049909.HKD","LU2552382058.USD","CANC","IYH","LU1868836757.USD","LU2023251221.USD","IE00BFSS8Q28.SGD","LU0133085943.USD","LLYX","LU2756315318.SGD","IE0004445015.USD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1691799644.USD","MEDX","LU2168563687.JPY","LU2357305700.SGD","LU1917777945.USD","BK4585","LLY","LU0889565916.HKD","THNR","SGXZ51526630.SGD","LU0094547139.USD","LU2746668461.USD","LU0320765059.SGD","SG9999001176.SGD","LU1868836914.USD","ELIL","LU2491050154.USD","LU0345770993.USD","IE00B775H168.HKD","LU0786609619.USD","LU1814569148.SGD","LU2106854487.HKD","WDNA","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0787776722.HKD","LU0353189763.USD","LU0882574139.USD","LU2089984988.USD","LU0238689110.USD","MHIP","LU0058720904.USD","IE00B2B36J28.USD","LU1064131342.USD","LU1988902786.USD","MEDI","LU0471298694.HKD","LU2063271972.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184177715","title":"New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management","url":"https://stock-news.laohu8.com/highlight/detail?id=1184177715","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184177715?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:52","pubTimestamp":1788249152,"startTime":"0","endTime":"0","summary":"Effective September 1, the updated 2026 edition of China's National Essential Medicines List is officially in force, marking a significant milestone as the first major revision since 2018. Among the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1093756168.USD","BK4588","NVOH","BK4532","JDOC","THNR","LU0154236417.USD","IE00BKVL7J92.USD","NVOC","PPH","OZEM","NVO","IE00BZ1G4Q59.USD","BK4007","NVOX","BK4585","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132713513","title":"Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=1132713513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132713513?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249011,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical giant Novartis AG (NVS.US) is experiencing a stark contrast in its neuro-immunology pipeline, as progress in one area is overshadowed by a serious setback in another. The company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PSYK","IBBJ","MEDX","MDTX","BK4007","BK4532","PPH","BMED","IE00B2B36J28.USD","IE0009355771.USD","NVS","LU0320765489.SGD","BK1574","BK4578","LU0208291251.USD","IBBQ","BK1191","IE00BFTCPJ56.SGD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0211331839.USD","01477"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":273,"code":"91000000","status":"200"}]}}